No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

byTeddy Guo

October 18, 2022

in StudyGraphics

Reading Time: 1 min read

Click to read this study in JAMA Otolaryngology – Head & Neck Surgery.

RELATED REPORTS

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

Greater thoracic aortic aneurysm size associated with worse long-term outcomes

RelatedReports

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

StudyGraphics

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

June 13, 2025

StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Jamie Foxx Back in Action, Paracetamol for Pain, FDA Against Addictive Vape Flavours, and Coffee and Tea, Beyond Caffeine:

January 7, 2025

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Sodium-glucose cotransporter-2 inhibitors for type 2 diabetes associated with reduced atrial fibrillation hospitalization events compared to commonly used comparators

Allopurinol does not reduce cardiovascular risk for patients with ischemic heart disease without gout

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result